Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 8.79677793 |
2 | negative thymic T cell selection (GO:0045060) | 8.12229695 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.08664201 |
4 | positive T cell selection (GO:0043368) | 7.56311353 |
5 | positive thymic T cell selection (GO:0045059) | 7.30550831 |
6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.18124732 |
7 | thymic T cell selection (GO:0045061) | 6.96964256 |
8 | T cell selection (GO:0045058) | 6.95082553 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.75831786 |
10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.64921161 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.61065633 |
12 | negative regulation of cell killing (GO:0031342) | 6.61065633 |
13 | interferon-gamma production (GO:0032609) | 6.56130196 |
14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.55981158 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.47583438 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.42478631 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.42478631 |
18 | response to interleukin-15 (GO:0070672) | 5.80655619 |
19 | * T cell receptor signaling pathway (GO:0050852) | 5.74256587 |
20 | cellular response to interleukin-15 (GO:0071350) | 5.54120341 |
21 | regulation of T cell tolerance induction (GO:0002664) | 5.47178210 |
22 | T cell migration (GO:0072678) | 5.38736659 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.34017726 |
24 | leukocyte aggregation (GO:0070486) | 5.28218411 |
25 | activated T cell proliferation (GO:0050798) | 5.27247471 |
26 | * T cell costimulation (GO:0031295) | 5.14767186 |
27 | * lymphocyte costimulation (GO:0031294) | 5.07327508 |
28 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.83668554 |
29 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.65848299 |
30 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.60218823 |
31 | positive regulation of interleukin-2 production (GO:0032743) | 4.48419791 |
32 | positive regulation of tolerance induction (GO:0002645) | 4.46808711 |
33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.43895363 |
34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.34756137 |
35 | V(D)J recombination (GO:0033151) | 4.32972900 |
36 | regulation of regulatory T cell differentiation (GO:0045589) | 4.31418006 |
37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.28654289 |
38 | positive regulation of isotype switching (GO:0045830) | 4.24404972 |
39 | T cell differentiation (GO:0030217) | 4.18649962 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.18335947 |
41 | alpha-beta T cell differentiation (GO:0046632) | 4.14532888 |
42 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.12090511 |
43 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.12090511 |
44 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.10334873 |
45 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.10334873 |
46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.09550235 |
47 | alpha-beta T cell activation (GO:0046631) | 4.07869402 |
48 | mast cell activation (GO:0045576) | 4.04234758 |
49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.99416607 |
50 | regulation of isotype switching (GO:0045191) | 3.97799982 |
51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.91955799 |
52 | regulation of tolerance induction (GO:0002643) | 3.90145631 |
53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.84114966 |
54 | tolerance induction (GO:0002507) | 3.78780478 |
55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.75567507 |
56 | detection of bacterium (GO:0016045) | 3.72977584 |
57 | detection of other organism (GO:0098543) | 3.69046675 |
58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68586462 |
59 | positive regulation of DNA recombination (GO:0045911) | 3.67431986 |
60 | T cell activation (GO:0042110) | 3.66971611 |
61 | neutrophil activation involved in immune response (GO:0002283) | 3.66391649 |
62 | regulation of response to interferon-gamma (GO:0060330) | 3.64409137 |
63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61299092 |
64 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61299092 |
65 | modulation by symbiont of host immune response (GO:0052553) | 3.61299092 |
66 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61299092 |
67 | modulation by symbiont of host defense response (GO:0052031) | 3.61299092 |
68 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61299092 |
69 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.60115255 |
70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.59645613 |
71 | positive regulation of B cell mediated immunity (GO:0002714) | 3.58443157 |
72 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.58443157 |
73 | B cell receptor signaling pathway (GO:0050853) | 3.56646462 |
74 | sequestering of actin monomers (GO:0042989) | 3.55423577 |
75 | positive regulation of humoral immune response (GO:0002922) | 3.53583212 |
76 | type I interferon signaling pathway (GO:0060337) | 3.52436788 |
77 | cellular response to type I interferon (GO:0071357) | 3.52436788 |
78 | cellular extravasation (GO:0045123) | 3.51940887 |
79 | response to type I interferon (GO:0034340) | 3.49984351 |
80 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.48103503 |
81 | positive regulation of B cell differentiation (GO:0045579) | 3.45059343 |
82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41656124 |
83 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.41156965 |
84 | T cell homeostasis (GO:0043029) | 3.40190187 |
85 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.39894150 |
86 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.37571930 |
87 | regulation of interleukin-2 production (GO:0032663) | 3.37150350 |
88 | regulation of B cell mediated immunity (GO:0002712) | 3.35373929 |
89 | natural killer cell activation (GO:0030101) | 3.31775590 |
90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.31147072 |
91 | mast cell degranulation (GO:0043303) | 3.29739407 |
92 | mast cell activation involved in immune response (GO:0002279) | 3.29739407 |
93 | neutrophil activation (GO:0042119) | 3.26734152 |
94 | leukocyte cell-cell adhesion (GO:0007159) | 3.25979650 |
95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.25879291 |
96 | regulation of immunoglobulin production (GO:0002637) | 3.24699868 |
97 | negative regulation of interleukin-12 production (GO:0032695) | 3.21962104 |
98 | positive regulation of immunoglobulin production (GO:0002639) | 3.19194607 |
99 | negative regulation of innate immune response (GO:0045824) | 3.19089460 |
100 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.18866495 |
101 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.18137166 |
102 | positive regulation of cell killing (GO:0031343) | 3.16492568 |
103 | regulation of cell killing (GO:0031341) | 3.16363843 |
104 | macrophage activation involved in immune response (GO:0002281) | 3.15608112 |
105 | T cell proliferation (GO:0042098) | 3.15593287 |
106 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.13129092 |
107 | leukocyte degranulation (GO:0043299) | 3.12524774 |
108 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12230163 |
109 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10464730 |
110 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10201230 |
111 | T-helper cell differentiation (GO:0042093) | 3.10201230 |
112 | cellular response to interleukin-4 (GO:0071353) | 3.10011469 |
113 | heterotypic cell-cell adhesion (GO:0034113) | 3.08562182 |
114 | respiratory burst (GO:0045730) | 3.08342107 |
115 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07519751 |
116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06379436 |
117 | T cell differentiation involved in immune response (GO:0002292) | 3.05597137 |
118 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.05597137 |
119 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.05597137 |
120 | * positive regulation of T cell activation (GO:0050870) | 3.05304758 |
121 | negative regulation of phagocytosis (GO:0050765) | 3.04317240 |
122 | dendritic cell chemotaxis (GO:0002407) | 3.03700391 |
123 | lymphocyte migration (GO:0072676) | 3.02892246 |
124 | regulation of alpha-beta T cell activation (GO:0046634) | 3.01835553 |
125 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.00493768 |
126 | myeloid cell activation involved in immune response (GO:0002275) | 3.00159092 |
127 | regulation of T cell mediated immunity (GO:0002709) | 2.99354992 |
128 | NIK/NF-kappaB signaling (GO:0038061) | 2.98968984 |
129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97210879 |
130 | response to muramyl dipeptide (GO:0032495) | 2.96973005 |
131 | granulocyte activation (GO:0036230) | 2.96493291 |
132 | positive regulation of T cell mediated immunity (GO:0002711) | 2.95834475 |
133 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.95809038 |
134 | cellular defense response (GO:0006968) | 2.93486745 |
135 | regulation of B cell differentiation (GO:0045577) | 2.92115512 |
136 | immunoglobulin mediated immune response (GO:0016064) | 2.92007856 |
137 | Peyers patch development (GO:0048541) | 2.91308984 |
138 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.91308984 |
139 | lymphocyte homeostasis (GO:0002260) | 2.88798141 |
140 | dendritic cell migration (GO:0036336) | 2.88622938 |
141 | regulation of granulocyte differentiation (GO:0030852) | 2.87237063 |
142 | natural killer cell differentiation (GO:0001779) | 2.86693591 |
143 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86159008 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.05221886 |
2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.98947196 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.44688423 |
4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.72745343 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69128918 |
6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.66867530 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 3.64893677 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.64312554 |
9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.61924853 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.43226235 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.38662062 |
12 | MYB_26560356_Chip-Seq_TH2_Human | 3.37697998 |
13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.95341306 |
14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.88105317 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86153814 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.84357067 |
17 | MYB_26560356_Chip-Seq_TH1_Human | 2.76602218 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59902016 |
19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.23818102 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21792777 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20634917 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20179183 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17250932 |
24 | * MAF_26560356_Chip-Seq_TH2_Human | 2.13931970 |
25 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.13042540 |
26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10915227 |
27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.07796170 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90984275 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89303377 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88717256 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78732728 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75585389 |
33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72744266 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71832449 |
35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69113688 |
36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68035195 |
37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66244761 |
38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65459812 |
39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62526023 |
40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60517737 |
41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59671490 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58974324 |
43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58905712 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55633167 |
45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53221092 |
46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51244085 |
47 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49473570 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49274073 |
49 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47913675 |
50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43687180 |
51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38279818 |
52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37021120 |
53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35956562 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34717493 |
55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33282019 |
56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30655775 |
57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24781779 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24456959 |
59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23186703 |
60 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.20788008 |
61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19984535 |
62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18818368 |
63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16701122 |
64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16292746 |
65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13166498 |
66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11330723 |
67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10297975 |
68 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.09955980 |
69 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09169017 |
70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08986558 |
71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08675134 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08522804 |
73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07277347 |
74 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04751062 |
75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00415943 |
76 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99427870 |
77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99371662 |
78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99281100 |
79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98643855 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98319932 |
81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96909207 |
82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96784769 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96142163 |
84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93208400 |
85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92727055 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92132699 |
87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91996343 |
88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90913139 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90570085 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90212063 |
91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90008430 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87747450 |
93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87224007 |
94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86530081 |
95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86038156 |
96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85970636 |
97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.85882033 |
98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85836050 |
99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84810162 |
100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84647607 |
101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82179751 |
102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.80949786 |
103 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80752605 |
104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80513041 |
105 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.79585688 |
106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79088327 |
107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78929720 |
108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78717469 |
109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.78666591 |
110 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78333596 |
111 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.75768440 |
112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.75358034 |
113 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.75209488 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74725404 |
115 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74576201 |
116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74046660 |
117 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.73973369 |
118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73317863 |
119 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69872206 |
120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68953384 |
121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.67530618 |
122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66811319 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0003763_abnormal_thymus_physiology | 6.08735243 |
2 | MP0005671_abnormal_response_to | 4.89493457 |
3 | MP0000685_abnormal_immune_system | 3.66030872 |
4 | MP0002166_altered_tumor_susceptibility | 3.43431584 |
5 | MP0001835_abnormal_antigen_presentation | 3.32253440 |
6 | MP0001800_abnormal_humoral_immune | 3.11144450 |
7 | * MP0000703_abnormal_thymus_morphology | 3.08244161 |
8 | * MP0002398_abnormal_bone_marrow | 2.97751344 |
9 | MP0005387_immune_system_phenotype | 2.87150000 |
10 | MP0001790_abnormal_immune_system | 2.87150000 |
11 | MP0002006_tumorigenesis | 2.85840044 |
12 | MP0005000_abnormal_immune_tolerance | 2.84417247 |
13 | * MP0002420_abnormal_adaptive_immunity | 2.84361121 |
14 | * MP0001819_abnormal_immune_cell | 2.79909839 |
15 | * MP0002723_abnormal_immune_serum | 2.72319798 |
16 | MP0009785_altered_susceptibility_to | 2.68939660 |
17 | MP0006082_CNS_inflammation | 2.59411986 |
18 | MP0002405_respiratory_system_inflammati | 2.59347749 |
19 | * MP0000716_abnormal_immune_system | 2.53606555 |
20 | * MP0009333_abnormal_splenocyte_physiolog | 2.51705398 |
21 | MP0002452_abnormal_antigen_presenting | 2.47905813 |
22 | * MP0002722_abnormal_immune_system | 2.46085311 |
23 | MP0005025_abnormal_response_to | 2.38516696 |
24 | MP0002396_abnormal_hematopoietic_system | 2.32975491 |
25 | MP0010155_abnormal_intestine_physiology | 2.29015170 |
26 | MP0001873_stomach_inflammation | 2.27981545 |
27 | * MP0000689_abnormal_spleen_morphology | 2.27962785 |
28 | MP0004947_skin_inflammation | 2.23788133 |
29 | MP0003436_decreased_susceptibility_to | 2.20761775 |
30 | MP0003300_gastrointestinal_ulcer | 2.18150483 |
31 | MP0003724_increased_susceptibility_to | 2.17841370 |
32 | MP0003866_abnormal_defecation | 2.07381935 |
33 | * MP0002429_abnormal_blood_cell | 2.06180679 |
34 | MP0004381_abnormal_hair_follicle | 1.93987464 |
35 | MP0002933_joint_inflammation | 1.92808162 |
36 | MP0002148_abnormal_hypersensitivity_rea | 1.83951364 |
37 | MP0002419_abnormal_innate_immunity | 1.64125960 |
38 | MP0001845_abnormal_inflammatory_respons | 1.63722477 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.61920381 |
40 | MP0000858_altered_metastatic_potential | 1.57258926 |
41 | MP0005464_abnormal_platelet_physiology | 1.53724542 |
42 | MP0001853_heart_inflammation | 1.51072238 |
43 | MP0002132_abnormal_respiratory_system | 1.42958539 |
44 | MP0004510_myositis | 1.42435726 |
45 | MP0008260_abnormal_autophagy | 1.35128408 |
46 | MP0003303_peritoneal_inflammation | 1.34300205 |
47 | MP0002009_preneoplasia | 1.30964008 |
48 | MP0005075_abnormal_melanosome_morpholog | 1.30676867 |
49 | MP0003191_abnormal_cellular_cholesterol | 1.29641628 |
50 | MP0005310_abnormal_salivary_gland | 1.29233226 |
51 | MP0003448_altered_tumor_morphology | 1.25813823 |
52 | MP0002277_abnormal_respiratory_mucosa | 1.23760452 |
53 | MP0000490_abnormal_crypts_of | 1.18724902 |
54 | MP0003828_pulmonary_edema | 1.16638637 |
55 | MP0002019_abnormal_tumor_incidence | 1.16610322 |
56 | MP0008057_abnormal_DNA_replication | 1.12457559 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.11104268 |
58 | MP0010094_abnormal_chromosome_stability | 1.09448690 |
59 | MP0005397_hematopoietic_system_phenotyp | 1.07943917 |
60 | MP0001545_abnormal_hematopoietic_system | 1.07943917 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.07631136 |
62 | MP0003172_abnormal_lysosome_physiology | 1.06276047 |
63 | MP0008469_abnormal_protein_level | 1.01587813 |
64 | MP0004883_abnormal_blood_vessel | 0.98248530 |
65 | MP0003077_abnormal_cell_cycle | 0.95509601 |
66 | MP0001851_eye_inflammation | 0.94313412 |
67 | MP0001533_abnormal_skeleton_physiology | 0.91861370 |
68 | MP0001986_abnormal_taste_sensitivity | 0.91696727 |
69 | MP0008961_abnormal_basal_metabolism | 0.85495152 |
70 | MP0009278_abnormal_bone_marrow | 0.85271089 |
71 | MP0004130_abnormal_muscle_cell | 0.83205876 |
72 | MP0004957_abnormal_blastocyst_morpholog | 0.83010221 |
73 | MP0003690_abnormal_glial_cell | 0.80597470 |
74 | MP0002998_abnormal_bone_remodeling | 0.78981482 |
75 | MP0005023_abnormal_wound_healing | 0.77608815 |
76 | MP0003693_abnormal_embryo_hatching | 0.77186125 |
77 | MP0005451_abnormal_body_composition | 0.76243981 |
78 | MP0005174_abnormal_tail_pigmentation | 0.73866240 |
79 | MP0005166_decreased_susceptibility_to | 0.72780739 |
80 | MP0008058_abnormal_DNA_repair | 0.71427610 |
81 | MP0003183_abnormal_peptide_metabolism | 0.70888752 |
82 | MP0005390_skeleton_phenotype | 0.69560986 |
83 | MP0005076_abnormal_cell_differentiation | 0.69514828 |
84 | MP0003045_fibrosis | 0.69172437 |
85 | MP0008007_abnormal_cellular_replicative | 0.67285629 |
86 | MP0002138_abnormal_hepatobiliary_system | 0.66688046 |
87 | MP0001243_abnormal_dermal_layer | 0.63134141 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.62759784 |
89 | MP0009763_increased_sensitivity_to | 0.62449099 |
90 | MP0005164_abnormal_response_to | 0.62076026 |
91 | MP0000604_amyloidosis | 0.58361829 |
92 | MP0000477_abnormal_intestine_morphology | 0.57732564 |
93 | MP0003111_abnormal_nucleus_morphology | 0.57294566 |
94 | MP0000249_abnormal_blood_vessel | 0.56625369 |
95 | MP0002095_abnormal_skin_pigmentation | 0.56224764 |
96 | MP0000609_abnormal_liver_physiology | 0.53899453 |
97 | MP0003795_abnormal_bone_structure | 0.51928168 |
98 | MP0000015_abnormal_ear_pigmentation | 0.51909353 |
99 | MP0000313_abnormal_cell_death | 0.51466013 |
100 | MP0001191_abnormal_skin_condition | 0.51109462 |
101 | MP0001348_abnormal_lacrimal_gland | 0.50181268 |
102 | MP0000350_abnormal_cell_proliferation | 0.46108674 |
103 | MP0001216_abnormal_epidermal_layer | 0.45834363 |
104 | MP0009764_decreased_sensitivity_to | 0.45711717 |
105 | MP0008874_decreased_physiological_sensi | 0.44747845 |
106 | MP0002136_abnormal_kidney_physiology | 0.44580781 |
107 | MP0002163_abnormal_gland_morphology | 0.43384603 |
108 | MP0001663_abnormal_digestive_system | 0.42784525 |
109 | MP0000367_abnormal_coat/_hair | 0.42771353 |
110 | MP0001765_abnormal_ion_homeostasis | 0.41927066 |
111 | MP0010307_abnormal_tumor_latency | 0.41646913 |
112 | MP0004185_abnormal_adipocyte_glucose | 0.41365811 |
113 | MP0003453_abnormal_keratinocyte_physiol | 0.41200249 |
114 | MP0002083_premature_death | 0.39338266 |
115 | MP0003787_abnormal_imprinting | 0.38737900 |
116 | MP0002693_abnormal_pancreas_physiology | 0.38665339 |
117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.38654363 |
118 | MP0008873_increased_physiological_sensi | 0.37983684 |
119 | MP0001919_abnormal_reproductive_system | 0.37838318 |
120 | MP0008770_decreased_survivor_rate | 0.37495665 |
121 | MP0005381_digestive/alimentary_phenotyp | 0.37490396 |
122 | MP0002928_abnormal_bile_duct | 0.37228954 |
123 | MP0003786_premature_aging | 0.36373010 |
124 | MP0008995_early_reproductive_senescence | 0.36100000 |
125 | MP0005058_abnormal_lysosome_morphology | 0.35943772 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * T lymphocytopenia (HP:0005403) | 8.23782575 |
2 | * Abnormality of T cell number (HP:0011839) | 7.89718801 |
3 | Severe combined immunodeficiency (HP:0004430) | 7.03057113 |
4 | Combined immunodeficiency (HP:0005387) | 6.66631795 |
5 | Panhypogammaglobulinemia (HP:0003139) | 5.68962215 |
6 | * Abnormality of T cells (HP:0002843) | 5.50746342 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.49090964 |
8 | B lymphocytopenia (HP:0010976) | 5.21360502 |
9 | Abnormality of B cell number (HP:0010975) | 5.21360502 |
10 | IgG deficiency (HP:0004315) | 5.06694850 |
11 | Recurrent bacterial skin infections (HP:0005406) | 4.97405285 |
12 | Recurrent fungal infections (HP:0002841) | 4.96533224 |
13 | Recurrent bronchitis (HP:0002837) | 4.79535440 |
14 | Stomatitis (HP:0010280) | 4.76989933 |
15 | Thyroiditis (HP:0100646) | 4.72670139 |
16 | Abnormality of macrophages (HP:0004311) | 4.60232994 |
17 | Nasal polyposis (HP:0100582) | 4.48296694 |
18 | Hypoplasia of the thymus (HP:0000778) | 4.44945190 |
19 | Chronic otitis media (HP:0000389) | 4.36121467 |
20 | IgM deficiency (HP:0002850) | 4.22055616 |
21 | * Recurrent viral infections (HP:0004429) | 4.20989629 |
22 | Autoimmune hemolytic anemia (HP:0001890) | 4.17156106 |
23 | Increased IgM level (HP:0003496) | 4.11000487 |
24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.96516378 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.96516378 |
26 | Abnormality of the fingertips (HP:0001211) | 3.88889065 |
27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.83845761 |
28 | Abnormality of the nasal mucosa (HP:0000433) | 3.75437434 |
29 | Pustule (HP:0200039) | 3.72843305 |
30 | Chronic diarrhea (HP:0002028) | 3.62691288 |
31 | Eczematoid dermatitis (HP:0000976) | 3.53275026 |
32 | Lymphopenia (HP:0001888) | 3.52712789 |
33 | Myositis (HP:0100614) | 3.52080026 |
34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47987455 |
35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.42176390 |
36 | Abnormality of T cell physiology (HP:0011840) | 3.36653622 |
37 | * Abnormality of eosinophils (HP:0001879) | 3.34388249 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 3.08500439 |
39 | Meningitis (HP:0001287) | 2.99492051 |
40 | Lymphoma (HP:0002665) | 2.96675765 |
41 | * Leukocytosis (HP:0001974) | 2.96022065 |
42 | * Eosinophilia (HP:0001880) | 2.95024587 |
43 | Hypochromic anemia (HP:0001931) | 2.93022990 |
44 | Basal cell carcinoma (HP:0002671) | 2.89874335 |
45 | Papilledema (HP:0001085) | 2.85794346 |
46 | Gingivitis (HP:0000230) | 2.83488760 |
47 | Spontaneous hematomas (HP:0007420) | 2.81330680 |
48 | Urticaria (HP:0001025) | 2.78740494 |
49 | Hypoproteinemia (HP:0003075) | 2.76971807 |
50 | Gastrointestinal infarctions (HP:0005244) | 2.72502773 |
51 | Bronchitis (HP:0012387) | 2.70295688 |
52 | Encephalitis (HP:0002383) | 2.69658479 |
53 | Hypergammaglobulinemia (HP:0010702) | 2.68700479 |
54 | Hemoptysis (HP:0002105) | 2.65061085 |
55 | Hypochromic microcytic anemia (HP:0004840) | 2.63129331 |
56 | * Granulocytopenia (HP:0001913) | 2.56477697 |
57 | IgA deficiency (HP:0002720) | 2.55615162 |
58 | Anorexia (HP:0002039) | 2.54414326 |
59 | Vasculitis (HP:0002633) | 2.54287983 |
60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.53000153 |
61 | Slow saccadic eye movements (HP:0000514) | 2.46610457 |
62 | Recurrent sinusitis (HP:0011108) | 2.44916638 |
63 | Gastrointestinal inflammation (HP:0004386) | 2.43428668 |
64 | Inflammation of the large intestine (HP:0002037) | 2.40500924 |
65 | Increased IgE level (HP:0003212) | 2.40308302 |
66 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.39678928 |
67 | Pulmonary infiltrates (HP:0002113) | 2.39146220 |
68 | Cellulitis (HP:0100658) | 2.37023400 |
69 | Stomach cancer (HP:0012126) | 2.36604633 |
70 | Mediastinal lymphadenopathy (HP:0100721) | 2.35902861 |
71 | Episodic fever (HP:0001954) | 2.35110880 |
72 | * Joint swelling (HP:0001386) | 2.34600356 |
73 | Verrucae (HP:0200043) | 2.34241431 |
74 | Papilloma (HP:0012740) | 2.34241431 |
75 | Colitis (HP:0002583) | 2.31832405 |
76 | Optic neuritis (HP:0100653) | 2.31664659 |
77 | Retrobulbar optic neuritis (HP:0100654) | 2.31664659 |
78 | Chronic sinusitis (HP:0011109) | 2.29519837 |
79 | Obstructive lung disease (HP:0006536) | 2.28626985 |
80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28626985 |
81 | Acute hepatic failure (HP:0006554) | 2.27845795 |
82 | Recurrent otitis media (HP:0000403) | 2.25410767 |
83 | Thrombocytosis (HP:0001894) | 2.24328836 |
84 | Hemiplegia (HP:0002301) | 2.22292101 |
85 | Recurrent skin infections (HP:0001581) | 2.18658487 |
86 | Gangrene (HP:0100758) | 2.18524640 |
87 | Sepsis (HP:0100806) | 2.15081201 |
88 | Bronchiectasis (HP:0002110) | 2.12627898 |
89 | Cheilitis (HP:0100825) | 2.12280506 |
90 | Recurrent abscess formation (HP:0002722) | 2.10925368 |
91 | Abnormal platelet volume (HP:0011876) | 2.09980800 |
92 | Abnormality of the pleura (HP:0002103) | 2.09383427 |
93 | Glomerulopathy (HP:0100820) | 2.06669056 |
94 | Orchitis (HP:0100796) | 2.06551832 |
95 | Keratitis (HP:0000491) | 2.05762965 |
96 | Agammaglobulinemia (HP:0004432) | 2.05018811 |
97 | Gastrointestinal stroma tumor (HP:0100723) | 2.02991814 |
98 | Cellular immunodeficiency (HP:0005374) | 2.02508870 |
99 | Ureteral stenosis (HP:0000071) | 2.02476147 |
100 | Epistaxis (HP:0000421) | 2.02324007 |
101 | Chest pain (HP:0100749) | 1.97458832 |
102 | Abnormality of the prostate (HP:0008775) | 1.97302521 |
103 | Osteomyelitis (HP:0002754) | 1.94652595 |
104 | Petechiae (HP:0000967) | 1.91850632 |
105 | Amaurosis fugax (HP:0100576) | 1.91597079 |
106 | Bicuspid aortic valve (HP:0001647) | 1.90707967 |
107 | Abnormality of the thymus (HP:0000777) | 1.90470242 |
108 | Prolonged bleeding time (HP:0003010) | 1.88484152 |
109 | Trigonocephaly (HP:0000243) | 1.87754487 |
110 | Ureteral obstruction (HP:0006000) | 1.86814364 |
111 | Poikiloderma (HP:0001029) | 1.85632436 |
112 | Keratoconjunctivitis sicca (HP:0001097) | 1.84445636 |
113 | Pulmonary embolism (HP:0002204) | 1.82864515 |
114 | Arterial thrombosis (HP:0004420) | 1.80635203 |
115 | Abnormality of oral frenula (HP:0000190) | 1.79075740 |
116 | Increased density of long bones (HP:0006392) | 1.77968365 |
117 | Hepatitis (HP:0012115) | 1.74753320 |
118 | Dislocated radial head (HP:0003083) | 1.72056292 |
119 | Gingival bleeding (HP:0000225) | 1.71051828 |
120 | Skin ulcer (HP:0200042) | 1.69974662 |
121 | Keratoconjunctivitis (HP:0001096) | 1.64836077 |
122 | Entropion (HP:0000621) | 1.63141949 |
123 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.62766330 |
124 | Periodontitis (HP:0000704) | 1.61966414 |
125 | Microcytic anemia (HP:0001935) | 1.60740184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.59176095 |
2 | MAP4K1 | 5.62157443 |
3 | TAOK3 | 3.56882208 |
4 | ITK | 3.54650494 |
5 | ZAP70 | 3.54462570 |
6 | RIPK4 | 3.18029571 |
7 | JAK3 | 3.08444814 |
8 | FGFR4 | 2.95948551 |
9 | PRPF4B | 2.75384877 |
10 | STK10 | 2.72206037 |
11 | IKBKE | 2.54353628 |
12 | GRK6 | 2.52967445 |
13 | TYK2 | 2.48519207 |
14 | NLK | 2.48264914 |
15 | FGFR3 | 2.01558440 |
16 | MST4 | 1.93308539 |
17 | * LCK | 1.90985721 |
18 | CSK | 1.79189310 |
19 | JAK1 | 1.78944345 |
20 | TEC | 1.72876982 |
21 | ERN1 | 1.67160047 |
22 | NME2 | 1.64559227 |
23 | MAP2K3 | 1.58501264 |
24 | MAP3K10 | 1.57827608 |
25 | MAP3K14 | 1.56983047 |
26 | SYK | 1.55940106 |
27 | EEF2K | 1.49479573 |
28 | HCK | 1.46105532 |
29 | KDR | 1.45657192 |
30 | TESK2 | 1.43268351 |
31 | BTK | 1.40329537 |
32 | TBK1 | 1.39381702 |
33 | PRKCQ | 1.28487458 |
34 | CAMKK2 | 1.27959542 |
35 | PRKCH | 1.19481900 |
36 | PKN2 | 1.13142763 |
37 | LRRK2 | 1.10409584 |
38 | CDK12 | 1.09414856 |
39 | CLK1 | 1.05472776 |
40 | CAMKK1 | 1.04243931 |
41 | MAP3K11 | 1.01969676 |
42 | BLK | 1.01889943 |
43 | FGR | 0.97687162 |
44 | MARK3 | 0.97630803 |
45 | MAP3K13 | 0.96278988 |
46 | MAP3K3 | 0.96162236 |
47 | RPS6KA4 | 0.96094388 |
48 | PDGFRB | 0.94847343 |
49 | TNK2 | 0.92462751 |
50 | IKBKB | 0.91754738 |
51 | MAP3K7 | 0.91333821 |
52 | SIK2 | 0.88294712 |
53 | JAK2 | 0.86565195 |
54 | PIM1 | 0.84914381 |
55 | MAP2K2 | 0.81388968 |
56 | MAP3K1 | 0.79231004 |
57 | TYRO3 | 0.73675161 |
58 | LYN | 0.71424798 |
59 | KIT | 0.70955688 |
60 | IRAK4 | 0.70809278 |
61 | TRIB3 | 0.68610186 |
62 | CDK4 | 0.66843966 |
63 | FES | 0.65964456 |
64 | EPHB1 | 0.63335005 |
65 | CHUK | 0.63138126 |
66 | SIK3 | 0.61934828 |
67 | MAPK7 | 0.61452075 |
68 | STK4 | 0.60055104 |
69 | CDC7 | 0.59179968 |
70 | MARK2 | 0.57619670 |
71 | PIK3CG | 0.56936887 |
72 | FGFR1 | 0.56540184 |
73 | BRD4 | 0.56248070 |
74 | TGFBR2 | 0.55592456 |
75 | PASK | 0.55229607 |
76 | STK38 | 0.55136267 |
77 | BMPR2 | 0.54314074 |
78 | HIPK2 | 0.53627681 |
79 | MELK | 0.53300623 |
80 | EPHA3 | 0.51196565 |
81 | ALK | 0.51080765 |
82 | FGFR2 | 0.49096673 |
83 | KSR2 | 0.45516860 |
84 | STK11 | 0.44537714 |
85 | TAOK2 | 0.44015464 |
86 | PDK1 | 0.43394266 |
87 | SMG1 | 0.42637343 |
88 | PRKD2 | 0.41849880 |
89 | CSF1R | 0.41730572 |
90 | DYRK1B | 0.41652939 |
91 | CDC42BPA | 0.41509884 |
92 | * INSR | 0.40162314 |
93 | MAPK11 | 0.40013285 |
94 | GRK7 | 0.39570431 |
95 | IGF1R | 0.38610237 |
96 | PDPK1 | 0.36847163 |
97 | TTN | 0.36490910 |
98 | FLT3 | 0.35983394 |
99 | NEK2 | 0.35702744 |
100 | SGK3 | 0.35155868 |
101 | TGFBR1 | 0.34996436 |
102 | MAP3K12 | 0.34420282 |
103 | MAP2K6 | 0.34318892 |
104 | * FYN | 0.33950651 |
105 | RPS6KB2 | 0.33883666 |
106 | PTK2B | 0.32912437 |
107 | CDK6 | 0.32525414 |
108 | MAPKAPK2 | 0.32450581 |
109 | RET | 0.32064622 |
110 | TSSK6 | 0.31775184 |
111 | MAPK4 | 0.31528035 |
112 | CDK9 | 0.31208419 |
113 | MAPK12 | 0.31111896 |
114 | IRAK1 | 0.30467395 |
115 | TAOK1 | 0.30038202 |
116 | NEK6 | 0.29513217 |
117 | STK24 | 0.29193569 |
118 | MAPK3 | 0.28970331 |
119 | MATK | 0.28918558 |
120 | RPS6KL1 | 0.28014771 |
121 | RPS6KC1 | 0.28014771 |
122 | MAP3K8 | 0.27758493 |
123 | ATR | 0.27395313 |
124 | CAMK4 | 0.26915108 |
125 | PTK6 | 0.23881870 |
126 | TLK1 | 0.23515646 |
127 | DMPK | 0.23000832 |
128 | RPS6KA5 | 0.22575461 |
129 | NUAK1 | 0.21630545 |
130 | RPS6KA6 | 0.20091800 |
131 | CHEK1 | 0.19188766 |
132 | YES1 | 0.19027845 |
133 | SIK1 | 0.17845579 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.31967354 |
2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.05872178 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25338988 |
4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.93697184 |
5 | Measles_Homo sapiens_hsa05162 | 2.84754786 |
6 | Allograft rejection_Homo sapiens_hsa05330 | 2.81853491 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78627389 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.72368422 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71069681 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46465085 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.27079368 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08225595 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91335068 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67737326 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63004524 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60522346 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59668606 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58999216 |
19 | Ribosome_Homo sapiens_hsa03010 | 1.53870264 |
20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48099630 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43123144 |
22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40393178 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37255079 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33763595 |
25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31266551 |
26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30276829 |
27 | Hepatitis B_Homo sapiens_hsa05161 | 1.24136048 |
28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23596700 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22069937 |
30 | HTLV-I infection_Homo sapiens_hsa05166 | 1.21035103 |
31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17567235 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17386282 |
33 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07245358 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.06711594 |
35 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06664058 |
36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03265335 |
37 | Spliceosome_Homo sapiens_hsa03040 | 1.01067261 |
38 | Shigellosis_Homo sapiens_hsa05131 | 0.97654949 |
39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96957314 |
40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96934545 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94837537 |
42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93222633 |
43 | Apoptosis_Homo sapiens_hsa04210 | 0.90486805 |
44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90324017 |
45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86896217 |
46 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83429261 |
47 | DNA replication_Homo sapiens_hsa03030 | 0.83421744 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81425856 |
49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79942381 |
50 | Asthma_Homo sapiens_hsa05310 | 0.77788115 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76415002 |
52 | Mismatch repair_Homo sapiens_hsa03430 | 0.75810976 |
53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74225693 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.73764361 |
55 | Platelet activation_Homo sapiens_hsa04611 | 0.73209991 |
56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71146996 |
57 | Legionellosis_Homo sapiens_hsa05134 | 0.70460532 |
58 | Base excision repair_Homo sapiens_hsa03410 | 0.68677688 |
59 | Malaria_Homo sapiens_hsa05144 | 0.66540376 |
60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66314006 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65336067 |
62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64767963 |
63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64490760 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64140646 |
65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63990343 |
66 | Phagosome_Homo sapiens_hsa04145 | 0.62360808 |
67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61351500 |
68 | RNA degradation_Homo sapiens_hsa03018 | 0.60409800 |
69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60383871 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58205766 |
71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57937363 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57443010 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56519617 |
74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56519383 |
75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55035620 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54823233 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54354747 |
78 | Salmonella infection_Homo sapiens_hsa05132 | 0.54236341 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53733018 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53175675 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52471512 |
82 | Tuberculosis_Homo sapiens_hsa05152 | 0.51506438 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48687553 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47507760 |
85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46609601 |
86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45778526 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45535306 |
88 | Prostate cancer_Homo sapiens_hsa05215 | 0.44967499 |
89 | RNA transport_Homo sapiens_hsa03013 | 0.43633547 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43204769 |
91 | Pertussis_Homo sapiens_hsa05133 | 0.42899770 |
92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42042662 |
93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41210096 |
94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40550964 |
95 | Cell cycle_Homo sapiens_hsa04110 | 0.40135314 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.39132369 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.39020740 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38689285 |
99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38371198 |
100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37676449 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37316700 |
102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36693754 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34459832 |
104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34135140 |
105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33920829 |
106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31162087 |
107 | Homologous recombination_Homo sapiens_hsa03440 | 0.30413441 |
108 | Proteasome_Homo sapiens_hsa03050 | 0.29874656 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29782793 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28528428 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28497859 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28401339 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28251694 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28010250 |
115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27460438 |
116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27164951 |
117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27135919 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27008587 |
119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26233604 |
120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25176459 |
121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24206021 |
122 | Insulin resistance_Homo sapiens_hsa04931 | 0.22352931 |
123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21592559 |